Literature DB >> 29437954

T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable.

Alok V Joglekar1, Zhe Liu2, Jeffrey K Weber3, Yong Ouyang2, John D Jeppson2, Won Jun Noh2, Pedro A Lamothe-Molina4, Huabiao Chen4, Seung-Gu Kang3, Michael T Bethune2, Ruhong Zhou5,6, Bruce D Walker4,7, David Baltimore1.   

Abstract

HIV controllers (HCs) are individuals who can naturally control HIV infection, partially due to potent HIV-specific CD8+ T cell responses. Here, we examined the hypothesis that superior function of CD8+ T cells from HCs is encoded by their T cell receptors (TCRs). We compared the functional properties of immunodominant HIV-specific TCRs obtained from HLA-B*2705 HCs and chronic progressors (CPs) following expression in primary T cells. T cells transduced with TCRs from HCs and CPs showed equivalent induction of epitope-specific cytotoxicity, cytokine secretion, and antigen-binding properties. Transduced T cells comparably, albeit modestly, also suppressed HIV infection in vitro and in humanized mice. We also performed extensive molecular dynamics simulations that provided a structural basis for similarities in cytotoxicity and epitope cross-reactivity. These results demonstrate that the differential abilities of HIV-specific CD8+ T cells from HCs and CPs are not genetically encoded in the TCRs alone and must depend on additional factors.

Entities:  

Keywords:  HIV controllers; T cell receptors; killer T cells

Mesh:

Substances:

Year:  2018        PMID: 29437954      PMCID: PMC5828616          DOI: 10.1073/pnas.1718659115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control.

Authors:  Zaza M Ndhlovu; Lori B Chibnik; Jacqueline Proudfoot; Seanna Vine; Ashley McMullen; Kevin Cesa; Filippos Porichis; R Brad Jones; Donna Marie Alvino; Meghan G Hart; Eleni Stampouloglou; Alicja Piechocka-Trocha; Carl Kadie; Florencia Pereyra; David Heckerman; Philip L De Jager; Bruce D Walker; Daniel E Kaufmann
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

4.  T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.

Authors:  Nina C Flerin; Huabiao Chen; Tynisha D Glover; Pedro A Lamothe; Jian Hua Zheng; Justin W Fang; Zaza M Ndhlovu; Evan W Newell; Mark M Davis; Bruce D Walker; Harris Goldstein
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

5.  CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection.

Authors:  S Zanussi; C Simonelli; M D'Andrea; C Caffau; M Clerici; U Tirelli; P DePaoli
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

Review 6.  Elite control of HIV Infection: implications for vaccines and treatment.

Authors:  Bruce D Walker
Journal:  Top HIV Med       Date:  2007 Aug-Sep

Review 7.  Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

Authors:  Joel N Blankson
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

8.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Authors:  Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; Stéphanie Gras; Takayuki Chikata; Nozomi Kuse; Solène Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Zaïna Aït Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

9.  Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.

Authors:  Daniel Mendoza; Stephen A Migueles; Julia E Rood; Bennett Peterson; Sarah Johnson; Nicole Doria-Rose; Douglas Schneider; Eva Rakasz; Matthew T Trivett; Charles M Trubey; Vicky Coalter; Claire W Hallahan; David Watkins; Genoveffa Franchini; Jeffrey D Lifson; Mark Connors
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

10.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Authors:  Jorge R Almeida; David A Price; Laura Papagno; Zaïna Aït Arkoub; Delphine Sauce; Ethan Bornstein; Tedi E Asher; Assia Samri; Aurélie Schnuriger; Ioannis Theodorou; Dominique Costagliola; Christine Rouzioux; Henri Agut; Anne-Geneviève Marcelin; Daniel Douek; Brigitte Autran; Victor Appay
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  8 in total

Review 1.  T cell antigen discovery.

Authors:  Alok V Joglekar; Guideng Li
Journal:  Nat Methods       Date:  2020-07-06       Impact factor: 28.547

2.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

3.  A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen.

Authors:  Rizwan Ahmed; Zahra Omidian; Adebola Giwa; Benjamin Cornwell; Neha Majety; David R Bell; Sangyun Lee; Hao Zhang; Aaron Michels; Stephen Desiderio; Scheherazade Sadegh-Nasseri; Hamid Rabb; Simon Gritsch; Mario L Suva; Patrick Cahan; Ruhong Zhou; Chunfa Jie; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

4.  In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers.

Authors:  David R Bell; Jeffrey K Weber; Wang Yin; Tien Huynh; Wei Duan; Ruhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-31       Impact factor: 11.205

5.  Commensal bacteria stimulate antitumor responses via T cell cross-reactivity.

Authors:  Catherine A Bessell; Ariel Isser; Jonathan J Havel; Sangyun Lee; David R Bell; John W Hickey; Worarat Chaisawangwong; Joan Glick Bieler; Raghvendra Srivastava; Fengshen Kuo; Tanaya Purohit; Ruhong Zhou; Timothy A Chan; Jonathan P Schneck
Journal:  JCI Insight       Date:  2020-04-23

Review 6.  CD8+ T cells in HIV control, cure and prevention.

Authors:  David R Collins; Gaurav D Gaiha; Bruce D Walker
Journal:  Nat Rev Immunol       Date:  2020-02-12       Impact factor: 53.106

Review 7.  Understanding the CD8 T-cell response in natural HIV control.

Authors:  Sushma Boppana; Paul Goepfert
Journal:  F1000Res       Date:  2018-07-02

Review 8.  Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy.

Authors:  Joanna A Warren; Genevieve Clutton; Nilu Goonetilleke
Journal:  Front Immunol       Date:  2019-02-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.